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Thymidylate synthase (TS) is a well validated target in cancer
chemotherapy. Here, a new crystal form of the R163K variant
of human TS (hTS) with five subunits per asymmetric part of
the unit cell, all with loop 181–197 in the active conformation,
is reported. This form allows binding studies by soaking
crystals in artificial mother liquors containing ligands that bind
in the active site. Using this approach, crystal structures of hTS
complexes with FdUMP and dUMP were obtained, indicating
that this form should facilitate high-throughput analysis of
hTS complexes with drug candidates. Crystal soaking experi-
ments using oxidized glutathione revealed that hTS binds this
ligand. Interestingly, the two types of binding observed are
both asymmetric. In one subunit of the physiological dimer
covalent modification of the catalytic nucleophile Cys195
takes place, while in another dimer a noncovalent adduct with
reduced glutathione is formed in one of the active sites.
Received 18 August 2010
Accepted 1 November 2010
PDB References: human
thymidylate synthase R163K,
complex with FdUMP, 3h9k;
complex with dUMP, 3hb8;
complex with glutathione,
3ob7.
1. Introduction
Thymidylate synthase (TS) catalyzes the reductive methyl-
ation of the nucleotide deoxyuridylate (dUMP) to thymidylate
(TMP) using 5,10-methylenetetrahydrofolate (mTHF) as a
cosubstrate (Humphreys & Greenberg, 1958). Substrates bind
to the active site in an ordered manner, with dUMP binding
prior to mTHF. The active-site cysteine (Cys195 in human TS)
attacks the 6-position of the pyrimidine base of the nucleotide,
resulting in the formation of a covalent bond between the
enzyme and the nucleotide, thus activating the 5-position of
the dUMP for subsequent covalent-bond formation with the
C-11 substituent of mTHF, forming a ternary complex
(reviewed in Stroud & Finer-Moore, 2003).
TS is a dimer of identical subunits that generate asymmetry
upon substrate/ligand binding (Danenberg & Danenberg,
1979; Dev et al., 1994). The enzyme is ubiquitous and highly
conserved among species; it is the sole source of de novo
thymidylate, which is required for DNA synthesis. Cessation
of this reaction not only halts cell replication but also leads to
apoptosis or necrosis of rapidly dividing cells, an effect named
‘thymineless death’ (Houghton, 1999). Inhibitors mimicking
either the substrate or cosubstrate have been developed as
chemotherapeutic agents. Their binding leads to strained
conformations of TS (Matthews et al., 1990; Montfort &
Weichsel, 1997).
Human TS (hTS) differs from bacterial TSs in three regions:
the N-terminus is extended by 28–29 residues and there are
two insertions of 12 and eight residues at positions 117 and
146, respectively (Carreras & Santi, 1995). hTS was originally
crystallized in high ammonium sulfate conditions and when its
structure was compared with those of other TS enzymes it was
observed that the catalytic loop 181–197 was rotated by
approximately 180 (Schiffer et al., 1995). This conformation,
thus far seen only in hTS, has the catalytic cysteine (Cys195
in hTS) out of the active site and therefore must be inactive.
In this inactive conformation of hTS, one of the eukaryotic
inserts, loop 107–128, is disordered and four sulfates per
subunit can be seen; they appear to stabilize the conformer.
However, hTS in an inhibitory complex with dUMP and
raltitrexed (Phan, Koli et al., 2001) has loop 107–128 ordered
and loop 181–197 in the active conformation. The conforma-
tional equilibrium of hTS is also affected by the N-terminus:
structural studies of hTS with residues 7–29 deleted showed
the enzyme in the active conformation (Almog et al., 2001),
while some Val3 mutants had an altered equilibrium (Huang et
al., 2010). The position of Trp182 is quite different in the active
and inactive conformations, which allowed Phan and co-
workers to monitor the confor-
mational equilibrium through the
use of intrinsic fluorescence
(Phan, Steadman et al., 2001). The
addition of phosphate, which
stabilizes the inactive conformer,
leads to an increase in hTS fluor-
escence, while the subsequent
addition of dUMP quenches this
increase. In solution, the active
and inactive conformations are in
equilibrium (Phan, Steadman et
al., 2001). The hTS variant R163K
was engineered to shift the equi-
librium towards the active con-
formation and it is apparent that
the design was successful (Gibson
et al., 2008).
In general, TS subunits show
negative cooperativity for sub-
strate, cosubstrate or inhibitor
binding. The ratio of the binding
constants, Kb, for the two subunits
depends strongly on the ligand
studied and on the source of the
enzyme. For hTS, measurements
of dUMP binding in a binary
complex by equilibrium dialysis
yielded a dissociation constant Kd
of 7.5 mM, with n = 0.90 per dimer
(Dev et al., 1994). This value
corresponds to the tighter binding
site, while the Kd for the weaker
site could not be measured using this technique. The binding
of 5-fluoro-20-deoxyuridine monophosphate (FdUMP) to hTS
Q214E showed a biphasic pattern with a ratio of binding
constants of about 6. Successful crystal binding studies typi-
cally use ligand concentrations that are much higher than the
Kd value, which therefore leads to binding in both subunits.
The only reported structure of a TS dimer with half of the sites
filled by ligands is that of Pneumocystis carinii (PcTS), for
which the folate Kb ratio is about 8000. In this structure (PDB
code 1ci7) PcTS is in complex with dUMP, which is present
in both active sites, and an antifolate cosubstrate inhibitory
analogue CB3717, which is present in only one (Anderson et
al., 1999). The subunit with bound inhibitor represents a
ternary inhibitory complex with a covalent bond between TS
and dUMP, while the other subunit represents only an adduct
of dUMP. For hTS, asymmetric binding of Pi was observed
in form 1 of R163K and the reactivity of hTS was also asym-
metric; the mutant displayed an asymmetric dimer in which
the catalytic cysteine was covalently modified in only one
subunit (Gibson et al., 2008).
Here, we report a new crystal form of hTS mutant R163K
(form 3) and crystal structures with bound FdUMP, dUMP and
glutathione. These structures display asymmetric ligand
binding in dimers.
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Table 1
Crystallographic data and refinement statistics for R163K form 3.
Values in parentheses are for the outer shell.
FdUMP dUMP Glutathione
X-ray source APS SER-CAT 22ID APS SER-CAT 22BM APS SER-CAT 22BM
Wavelength (A˚) 1.0 1.0 0.92
No. of frames (high pass/low pass) 200/200 360 288
Oscillation range () 1.0 0.5 0.5
Crystal-to-detector distance (mm) 300/350 300 300
Temperature (K) 100 100 100
Space group C2 C2 C2
Unit-cell parameters
a (A˚) 200.284 196.459 201.80
b (A˚) 122.190 122.149 123.11
c (A˚) 99.828 99.157 99.93
 () 115.18 114.551 115.8
Volume (A˚3) 2210928 2164371 2236989
Solvent content (%) 60.53 59.68 60.97
Matthews coefficient (A˚3 Da1) 3.11 3.05 3.15
Mosaicity () 0.52 0.64 0.89
Resolution range (A˚) 50.0–2.65 (2.74–2.65) 50.0–2.74 (2.84–2.74) 45.5–2.75 (2.85–2.75)
Average multiplicity 4.9 3.0 2.7
Average I/(I) 11.4 18.3 13.7
Total No. of reflections 312575 157053 138780
No. of unique reflections 59470 50175 46360
Completeness (%) 99.7 (98.0) 96.7 (82.6) 89.1 (55.8)
Total linear Rmerge 11.0 6.9 7.6
R (CNS) (%) 21.4 21.0 23.8
Rfree (CNS) (%) 26.0 26.2 27.5
Ramachandran statistics, residues in
Most favored regions (%) 84.3 85.5 77.2
Additional allowed regions (%) 15.3 14.2 21.1
Generously allowed regions (%) 0.4 0.3 1.7
Disallowed regions (%) 0.0 0.0 0.0
Average B factors (A˚2)
Subunit A 47.1 49.1 65.4
Subunit B 56.5 57.5 77.3
Subunit C 52.9 50.1 79.4
Subunit D 71.0 62.3 92.1
Subunit E 60.8 54.8 92.0
2. Materials and methods
2.1. Chemicals
Salts, -mercaptoethanol (BME), polyethylene glycols
(PEGs), 20-deoxyuridine-50-monophosphate (dUMP) and
5-fluoro-20-deoxyuridine monophosphate (FdUMP) were
obtained from Sigma (St Louis, Missouri, USA). (6S)-5,6,7,8-
Tetrahydrofolic acid (H4folate) was prepared from folic acid
and converted to (6R)-CH2H4folate (mTHF) as described
previously (Steadman et al., 1998). l-Oxidized glutathione was
obtained from Acros Organics (Morris Plains, New Jersey,
USA).
2.2. Protein expression and crystallization
A plasmid containing the hTS mutant R163K (Gibson et al.,
2008) was transformed into the Escherichia coli TX61
(thyA) bacterial strain, which does not produce its own
thymidylate synthase enzyme (Dev et al., 1988). R163K hTS
was expressed and purified following procedures previously
developed for hTS (Phan, Steadman et al., 2001) with only
minor modifications. Briefly, cell-free extract was separated on
a Q-Sepharose anion-exchange column using a 0–100% satu-
rated KCl gradient. The active fractions were pooled, dialyzed
and separated on a Blue Sepharose CL-6B column using a
similar gradient. The active fractions were again pooled,
dialyzed and separated a second time on the Q-Sepharose
anion-exchange column using a similar gradient. The active
fractions were then pooled, concentrated to 12 mg ml1 and
analyzed for purity on an SDS–PAGE gel. R163K crystals
were grown under low-salt conditions (100 mM Tris pH 9.0,
20 mM BME, 3 mM KH2PO4, 10–20% PEG 4K) by hanging-
drop vapor diffusion at 277 K.
2.3. Data collection and processing
Crystals were transferred into soaking solution (100 mM
Tris pH 9.0, 20 mM BME, 3 mM KH2PO4, 10–20% PEG 4K)
plus ligand (3 mM FdUMP and 2 mM mTHF or 3 mM dUMP
and 2 mM mTHF) or soaking solution without BME and with
1 mM l-oxidized glutathione and soaked for 2 min. Crystals
were then transferred to a cryosolution containing an addi-
tional 20% ethylene glycol and flash-frozen in a liquid-N2
vapor stream.
X-ray diffraction data were collected on the SER-CAT
22ID or 22BM beamlines at the Advanced Photon Source,
Argonne National Laboratory. The data were indexed and
processed with theHKL-2000 software (Otwinowski &Minor,
1997); processing parameters and statistics are summarized in
Table 1.
2.4. Structure determination and refinement
The initial structure of R163K form 3 was solved by mole-
cular replacement with the CNS software (Bru¨nger et al.,
1998) using the hTS–dUMP–raltitrexed structure (PDB code
1hvy; Phan, Koli et al., 2001) without ligands as the search
model. Subsequent structures of R163K form 3 with ligands
bound were solved by molecular replacement with the CNS
software (Bru¨nger et al., 1998) using the native R163K form 3
structure as the search model. Structure rebuilding and sub-
sequent refinements were performed using the TURBO soft-
ware (Roussel & Cambillau, 1991) and CNS (Bru¨nger et al.,
1998), respectively. Dictionary files for the cysteine residue
covalently modified by glutathione were created starting from
GSH and CME topology and parameter files from HIC-Up
(Kleywegt & Jones, 1998). Superpositions were calculated
using the LSQKAB program (Kabsch, 1976) from the CCP4
suite (Collaborative Computational Project, Number 4, 1994).
Ligand occupancies were calculated using SHELXL (Shel-
drick, 2008). Figures were prepared using TURBO (Roussel &
Cambillau, 1991), MolScript (Kraulis, 1991) and Raster3D
(Merritt & Bacon, 1997).
3. Results and discussion
3.1. Crystallization
It has been shown previously that hTS mutant R163K has a
propensity for polymorphism (Gibson et al., 2008). Crystals of
R163K form 3 appeared after 3–4 d in the same crystallization
conditions as the previously reported R163K crystal forms 1
and 2. Form 3 belongs to space group C2 and has five subunits
per asymmetric part of the unit cell (two dimers, A/B andD/E,
are in general positions, while subunit C forms a dimer with its
symmetry equivalent via a twofold crystallographic axis). The
previously reported structures of R163K crystal forms 1 and 2
belonged to space group P3221 and had six and two subunits
per asymmetric part of the unit cell, respectively (Gibson et al.,
2008).
3.2. Conformation of loop 181–197
Loop 181–197 of wild-type hTS (wt-hTS) populates two
conformations in solution: one active and the other inactive.
The number of conformers appears to be similar: kinetic data
suggest that in the minimum energy state an asymmetric dimer
exists with one subunit in the active conformation and the
second in an inactive conformation (Lovelace et al., 2007).
High-quality crystals of wt-hTS were previously obtained in
the presence of ammonium sulfate because sulfate ions (and
phosphate ions) strongly stabilize the inactive conformer,
leading to symmetric molecules that are more likely to form
well ordered crystals. The inactive conformer, however, does
not bind substrate analogues and the crystals obtained using
ammonium sulfate are useless for most inhibitor-binding
studies.
In all of the subunits present in the structures of form 3, as
in the previously studied forms 1 and 2, the eukaryotic insert 1
(loop 107–128) is ordered and the catalytic loop (residues 181–
197) is in the active conformation, positioning the catalytic
residue Cys195 in the active site. All individual subunits, when
superposed, are very similar, with the r.m.s. distance of C
positions varying in the range 0.24–0.70 A˚. Thus, the R163K
variant of hTS has the inactive conformer destabilized and its
crystals, as reported here, are suitable for studies of inhibitor
binding that do not lead to large conformational changes.
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Inhibitor binding that induces the closure of
the C-terminus apparently affects crystal
packing and leads to a deterioration in
crystal quality.
3.3. hTS complexes with the substrate and
inhibitor
Crystals were soaked with either FdUMP/
mTHF or dUMP/mTHF mixtures; however,
only binary complexes were obtained. The
two dimers present in general positions have
one subunit with a very high occupancy of
the nucleotide, while the other subunit has
only partial occupancy of the soaked ligand.
In these partially filled subunits strong
density corresponding to a phosphate ion
(which is present at 3 mM in the crystal-
lization medium) was observed at the active
site, indicating that in the absence of a
nucleotide a phosphate ion binds. Even
though both the FdUMP and dUMP soaks
also contained the cosubstrate mTHF, no
density for the folate was seen in any of the
subunits, while the density for the nucleo-
tides was quite good. This may indicate that
diffusion of the nucleotide into the crystal is
quick but diffusion of the larger folate is
much slower. Birdsall et al. (1996) were able
to grow cocrystals of Lactobacillus casei TS
with dUMP and subsequently soak them in
mTHF and antifolates over the course of
approximately 2 d. Longer soaking times
were performed with R163K crystals; however, diffraction by
these crystals was poor and data collection was not possible. In
contrast, a crystal soaked in FdUMP or dUMP only retained
diffracting power. This suggests that the formation of tertiary
complexes eventually took place, but the transition to the
more compact conformation of these complexes affected
crystal packing.
3.3.1. FdUMP complex. At a contour level of  = 1.0 density
that corresponds to FdUMP can be seen in subunits A, B and
D; at a lower contouring level of  = 0.6 density can also be
seen in subunit E. Refinement with SHELXL (Sheldrick,
2008) was used to estimate the occupancy of FdUMP in each
subunit. In the first dimer (A/B) subunit A has full occupancy
for FdUMP, while the occupancy in subunit B was calculated
to be approximately half. The half occupancies calculated with
SHELX were likely to be overestimates (because a phosphate
ion is likely to be present in the absence of nucleotide), but are
consistent with the density observed (Fig. 1). No covalent
bond is seen between the FdUMP and Cys195, thus reflecting
the observation that the nucleotide does not form a covalent
bond to the catalytic cysteine until a folate binds (Stroud &
Finer-Moore, 2003).
Ethylene glycol, which was present in the cryosolution, has
been modeled into density found in the active sites of subunits
research papers
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Figure 2
Superposition of dimer A/B on dimer B/A (shown in blue and pink) of
hTS R163K form 3 soaked with FdUMP. The soaked ligands FdUMP and
BME are shown in dark gray in dimer A/B, while in dimer B/A they are
shown in light gray. FdUMP and BME occupy both active sites, but have
full occupancy in subunit A and only partial occupancy in subunit B. This
superposition reveals no significant differences at the subunit interface.
Figure 1
(a) Stereoview of the hTS active site in subunit A with full occupancy of the ligand FdUMP. (b)
Stereoview of the active site in subunit B with partial occupancy of the ligand FdUMP. The
Fo  Fc map (green) is contoured at the 2 level, with the density of neighboring residues
shown in the 2Fo  Fc map (blue) contoured at the 1 level.
A and B. This density is not large enough to
represent the much larger mTHF; rather, its
presence indicates that at the 3.6M
concentration in the cryosolvent glycol
competes with mTHF binding. Even though
the subunits that form a dimer do not bind
FdUMP equally, superposition of subunitsA
and B yielded an r.m.s. distance between the
C positions of only 0.40 A˚. Fig. 2 shows this
superposition; it reveals no significant
differences at the subunit interface.
Superposition of subunit A of the
FdUMP-soaked R163K form 3 structure
with subunit A of R163K form 2 (PDB entry
2rd8; Gibson et al., 2008) yielded an r.m.s.
distance between the C positions of 0.25 A˚,
while superposition of subunit B of R163K
form 2 yielded an r.m.s. distance of 0.60 A˚.
This difference, while small, could be
attributed to the modification of Cys195 by
BME, which is present in subunit B of
R163K form 2 but is not present in subunit
A.
3.3.2. dUMP complex. In the structure of
R163K form 3 soaked with dUMP, full
occupancy is seen for dUMP in subunits A
and D, while subunits B and E (the
complementary halves of the dimers) mostly
have phosphate in their active sites (Fig. 3).
There is moderate density for dUMP (more
than phosphate) in subunit C, which forms a
dimer with a symmetry-equivalent subunit.
As in the structure of R163K form 3 with
FdUMP, the R163K form 3 structure soaked
with dUMP also displays no covalent bond
between Cys195 and the nucleotide in the
active site. As expected, the structures of
R163K form 3 with dUMP and FdUMP in
the active site are almost identical; super-
position of subunit A from dUMP–R163K
with subunit A of the FdUMP–R163K
structure gives an r.m.s. distance of only
0.24 A˚.
3.4. Glutathione complex
R163K form 2 (PDB code 2rd8) displayed
two environments for the catalytic cysteine
Cys195: (i) unmodified cysteine, in which the
thiol is closer to the O atom of the Ser216
backbone and farther from the guanidinium
group of Arg215, and (ii) cysteine forming a
disulfide bond with a molecule of BME, in
which the thiol is closer to the guanidinium
group of Arg215 and farther from the O
atom of the Ser216 backbone (Gibson et al.,
2008). This variability was correlated with
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Figure 3
(a) Stereoview of the Fo  Fc electron density (shown at the 2 level) corresponding to dUMP
in subunit A with full occupancy and (b) stereoview of the Fo  Fc electron density (shown at
the 2 level) corresponding to phosphate in subunit B.
Figure 4
(a) Stereoview of the Fo  Fc electron density (shown at the 2 level) corresponding to
nonbonded glutathione (GSH) in the hTS active site in subunit A. (b) Stereoview of the hTS
active site in subunit D with a covalently modified Cys195D-linked glutathione; the difference
map is contoured at the 2 level.
the altered pKa of the thiol in these environments. BME,
which is used as a reducing agent in vitro, is not present within
cells. The most prevalent nonprotein thiol found in mamma-
lian cells is reduced glutathione (GSH). This tripeptide,
consisting of Glu-Cys-Gly, is not only the primary reducing
agent and cofactor for many antioxidant enzymes, but also acts
as an intermediary in various other physiological reactions,
such as being an essential cysteine reservoir, and participates
in thiol–disulfide exchange (Franco et al., 2007). To investigate
the interaction of hTS with GSH, we soaked crystals of form 3
with oxidized glutathione (GS-SG), expecting to see modifi-
cation of either one or both subunits. Somewhat unexpectedly,
only one of five subunits contained covalently bound gluta-
thione, while one contained reduced GSH. Apparently, there
was a sufficient amount of GSH in the soaking solution, which
was likely to have been generated from residual BME, to
selectively bind within subunit A. Electron density for the
active site of subunit A clearly indicates that glutathione is
reduced. In contrast, a covalent bond forms between Cys195
and glutathione in subunit D (Fig. 4). The 12 October 2010
release of the PDB contains 71 structures that contain gluta-
thione, nine of which are of an enzyme covalently modified by
GSH. However, the hTS complex is the only structure that has
one subunit with a covalently bound glutathione and another
subunit in which a noncovalent adduct is present.
The mosaicity of the glutathione-complex crystal was higher
than the mosaicities of the crystals soaked in nucleotides. The
B factors are also higher and significantly different. Dimer 1
has average B factors of 65.4 A˚2 for subunit A and 77.3 A˚2 for
subunit B. Dimer 2 has average B factors of 92.1 A˚2 for sub-
unit D and 92.0 A˚2 for subunit E and the overall density for
these subunits was not good. It is not unlikely that some other
cysteine residues (there are five per subunit) underwent
partial derivatization, therefore inducing crystal damage.
Since both reduced and oxidized forms of glutathione are
present in the cytosol, it appears that the TS active-site
architecture should be such as to prevent entrance of GS-SG
to protect its catalytic thiol from oxidation while promoting
access of GSH to keep Cys195 reduced. This may be an
explanation of our observation that despite a large excess of
GS-SG over GSH a complex with GSH was observed.
The superposition of R163K form 3 complexes shows that
glutathione occupies the same space within the active site as
the hTS complexes with substrates and their analogs (Fig. 5).
3.5. Communication between the active sites of the hTS
dimer
Studies of asymmetric ligand binding in crystals always
involve some serendipity. To observe asymmetric ligand
binding there must be some correlation between crystal
environment and asymmetry, otherwise disorder occurs. The
reverse can also happen: a dimer with no subunit cooperativity
can crystallize in such a fashion that the crystal environment
stabilizes the positions of active-site loops such that ligand
binding takes place preferentially in one subunit but not in the
other. There is ample evidence for
negative cooperativity in TS dimers in
solution (Dev et al., 1994), but the
structural information is limited
(Anderson et al., 1999). Clearly, for hTS
we observe differences in ligand occu-
pancies between subunits. The partial
occupancy that is observed, rather than
zero occupancy, may arise from a
combination of factors. Firstly, the
concentrations of the ligands in the
artificial mother liquors were fairly high
and this may have overcome the nega-
tive cooperativity. Secondly, the corre-
lation between crystal environment and
dimer asymmetry may not be sufficient
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Figure 5
The active site of hTS with superposition of ligands. Comparison of the
R163K form 3 complexes with the cocrystallized hTS–dUMP–raltitrexed
structure (PDB code 1hvy; Phan, Koli et al., 2001) shows the soaked
ligands occupying the same space within the active site as hTS
cocrystallized with ligands. The FdUMP binary complex is shown in
atom-type colors, dUMP from the ternary inhibitory complex with
raltitrexed (PDB code 1hvy) in pink, dUMP in the binary complex in
green and the glutathione noncovalent adduct in blue.
Figure 6
Potential model for communication between the active sites of the hTS dimer. SubunitA is shown in
green, subunit B is shown in pink and dUMP and phosphate are shown in blue. Residues Gln214,
Arg215 and Ser216, which all interact with the nucleotide, pull Tyr213, which interacts with its
symmetry equivalent Tyr2130 and affects Gln2140, Arg2150 and Ser2160, therefore altering the
affinity for the nucleotide in the other subunit.
to induce ligand ordering in the lattice. Thirdly, active-site
accessibility via diffusion may be an important factor in
crystal-soaking experiments.
The observed partial ordering of ligands is not reflected by
asymmetry of the dimers. One reason for this is that the
residues involved in generating negative cooperativity, and
thus asymmetry, are averages of protein structures reflecting
ligand occupancies. Also, since the nucleotide-binding con-
stants for the dimer subunits only differ by a factor of six or so,
the structural differences between the subunits must be subtle
and apparently could not be resolved with the limited data
resolution. The differences in nucleotide occupancies between
FdUMP and dUMP complexes (Figs. 1 and 3) suggest that the
observed asymmetric binding is not a result of the diffusion
process but rather relates to binding affinities.
One model that can be proposed for subunit communica-
tion involves residues Gln214-Arg215-Ser216, which all
interact with the nucleotide. They pull Tyr213, which interacts
with Tyr2130 from the other subunit, and affect Gln2140-
Arg2150-Ser2160, thus altering the affinity for the nucleotide in
the other subunit (Fig. 6). In addition to its simplicity, the main
argument for this model is its analogy to the negative co-
operativity mechanism proposed for folate binding in PcTS, in
which these residues are conserved. In the PcTS asymmetric
dimer, which is composed of a ternary complex in one subunit
and a binary complex in the other, the positions of these
residues differ by about 0.3 A˚. Consequently, the residues
have been proposed to be involved in subunit communication
(Anderson et al., 1999). In the structures reported here
differences in protein geometry are not observed, but partial
occupancies and much smaller structural differences induced
by nucleotide binding versus folate binding, as judged by the
ratios of Kb values, are likely to be responsible for such an
outcome. The structures of forms 1 and 2 of R163K (PDB
codes 2rda and 2rd8) show asymmetry within the dimer that is
associated with phosphate-ion binding; the crystals of form 3
reflect the ability of R163K to asymmetrically bind ligands.
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